Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpubmed.ncbi.nlm.nih.gov
Тафинлар + Мекинист
Get the latest updates from Тафинлар + Мекинист directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 4 years ago
Papillary Thyroid Cancer Differentiating Into Anaplastic Carcinoma With Near-Complete Response to Targeted Dabrafenib/Trametinib Combination Therapy
over 4 years ago
Cureus. 2021 Dec 25;13(12):e20693. doi: 10.7759/cureus.20693. eCollection 2021 Dec.ABSTRACTAnaplastic thyroid cancer is...
BAMM (BRAF Autophagy and MEK inhibition in Melanoma): A phase I/II trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600-mutant melanoma
over 4 years ago
Clin Cancer Res. 2022 Jan 12:clincanres.3382.2021. doi: 10.1158/1078-0432.CCR-21-3382. Online ahead of print.ABSTRACTPURPOSE...
Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report
over 4 years ago
Dermatol Ther. 2022 Jan 4:e15301. doi: 10.1111/dth.15301. Online ahead of print.NO ABSTRACTPMID:34984776...
Early Experience with Dabrafenib-Trametinib Combination in Patients with BRAF-Mutated Malignant Melanoma-A Single-Center Experience
over 4 years ago
South Asian J Cancer. 2021 Nov 24;10(3):187-189. doi: 10.1055/s-0041-1736032. eCollection 2021 Sep.ABSTRACTBackground...